Brevibloc Premixed (esmolol): Reviews and patient testimonials

Brevibloc Premixed 10 mg/ml Solution for Infusion

Brevibloc is indicated for supraventricular tachycardia (except for pre-excitation syndromes), and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable. Brevibloc is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia where, in the physician's judgment the rapid heart rate requires specific intervention.

Brevibloc is not indicated for use in children aged up to 18 years. Brevibloc is not intended for use in chronic settings.

Brevibloc Premixed 10 mg/ml Solution for Injection

Brevibloc is indicated for supraventricular tachycardia (except for pre-excitation syndromes), and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable. Brevibloc is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia where, in the physician's judgement the rapid heart rate requires specific intervention.

Brevibloc is not indicated for use in children aged up to 18 years. Brevibloc is not intended for use in chronic settings.

Route of administration: Injectable
Molecule: esmolol